Dr. Reddy's Laboratories
Search results
Jun 24, 2024 · Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs.
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]
A global biopharmaceutical company changing patients’ lives by finding new & affordable ways to treat diabetes, cancer & autoimmune diseases.
It’s a chance to work alongside some of the brightest minds in research, healthcare, pharmaceutical, biotechnology and business sectors. With a talented and diverse team, which works towards the common goal of making healthcare affordable and accessible globally, the possibilities are endless. MORE >>.
4 days ago · Biocon Share Price Today (28 Jun, 2024): Biocon Stock Price (₹ 351.10) Live NSE/BSE updates on The Economic Times. Check out why Biocon share price is up today. Get all details on Biocon Ltd.shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more
Biocon Biologics Ltd on Monday announced that it has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new multi-product monoclonal antibodies ...
Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals. Global scale manufacturing set up for biologics, biosimilars.
Jun 22, 2024 · NEW DELHI: Biotechnology player Biocon on Saturday said the US health regulator has issued four observations after inspecting its manufacturing plant in Andhra Pradesh. The US Food and Drug Administration concluded a GMP inspection of the company's API facility (Site 5), located at Visakhapatnam, Andhra Pradesh, on June 21, 2024, the company said in a regulatory filing."Four observations were cited at the end of the inspection, which we will be addressing within the stipulated time," it added.
Biocon evolved from manufacturing speciality enzymes to pharmaceuticals like statins and immunosuppressants, to discovering, developing, and producing life-saving biotherapeutics. It has been a journey of endurance over several decades - from being the ‘first Indian company’ to win U.S. Food & Drugs Administration (FDA) approval for ...
Jun 23, 2024 · Biocon: The US Food and Drug Administration (USFDA) concluded a GMP inspection of the company's API facility (Site 5), located at Visakhapatnam, Andhra Pradesh, on June 21, 2024, the company said ...
